Cancer-Myelofibrosis and Essential Thrombocythemia-MOST
| Title | Myelofibrosis and Essential Thrombocythemia Observational Study (MOST) |
|---|---|
| Description | The MOST study is an observational research study for adults 18 and over who have been diagnosed with myelofibrosis or essential thrombocythemia. The study will be conducted at about 250 sites in the U.S., and will recruit about 500 adults with myelofibrosis and 1,000 with essential thrombocythemia. For additional information visit ClinicalTrials.gov |
| NCT Number | 02953704 |
| Start Date | 01/17/2017 |
| Status | Follow up; closed to enrollment |
| Principal Name | Kerry Pulver, MD |
| Contact Name | Olga Bittner, MHS, CCRC |
| Phone | 208-367-7954 |